Session » Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy I: Treatment Strategies
-
Abstract Number: 951
A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry